NeuraMatrix
Beijing · Founded 2019
About NeuraMatrix
NeuraMatrix is a cutting-edge brain-computer interface technology developer. It uses cutting-edge question-computer interface technology to establish the ultimate way and platform for interactive human-computer information interaction, and realizes a one-stop service solution from hardware to software to digital devices. Influencing factors in brain science, neurological disease research, diagnosis and treatment, and innovating the new drug research and development evaluation system for neurological diseases, the wellhead is leveraging the enormous commercial application value of brain-computer interfaces. Recently completed 100 million yuan A round of financing, led by Huagai Capital, Saudi Aramco's diversified venture capital fund Prosperity7 Ventures, and old shareholder Jingwei China joined the investment. This round of financing will be mainly used for R&D equipment update, chip mass production, product iteration and market promotion.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2021)
- Website: http://www.neuramatrix.com.cn/
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical, Medical Device, Neuroscience
Canonical: https://fsome.com/organization/neuramatrix-150675 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.